Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK)

Researchers planned a randomized trial, meaning people were assigned by chance to receive vitamin K2 or a comparison treatment. The participants were adults on hemodialysis, a treatment that filters the blood when the kidneys no longer work well. The study was designed to measure whether vitamin K2 reduced vascular calcification, the buildup of calcium that can stiffen and narrow blood vessels. No results or participant number are provided in this record.

What this means for you: This record does not show that vitamin K2 prevents artery hardening or improves health in people on dialysis. You should not buy it for this purpose based on this study alone.